These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34084217)

  • 1. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma.
    Nakagawa N; Sonohara F; Tanaka K; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Oncol Lett; 2021 Jul; 22(1):538. PubMed ID: 34084217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
    Liu M; Zhao Z; Cai Y; Bi P; Liang Q; Yan Y; Xu Z
    Aging (Albany NY); 2021 Nov; 13(21):24205-24218. PubMed ID: 34747720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.
    Tsuchiya K; Yoshimura K; Inoue Y; Iwashita Y; Yamada H; Kawase A; Watanabe T; Tanahashi M; Ogawa H; Funai K; Shinmura K; Suda T; Sugimura H
    Oncoimmunology; 2021; 10(1):1962656. PubMed ID: 34408926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
    Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-145 Modulates
    Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
    J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic Analyses of the Role of the Reader Protein of
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
    Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
    Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma.
    Koh YW; Han JH; Haam S; Lee HW
    Front Oncol; 2022; 12():996634. PubMed ID: 36479088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
    Hou J; Zhang H; Liu J; Zhao Z; Wang J; Lu Z; Hu B; Zhou J; Zhao Z; Feng M; Zhang H; Shen B; Huang X; Sun B; Smyth MJ; He C; Xia Q
    Mol Cancer; 2019 Nov; 18(1):163. PubMed ID: 31735169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
    Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
    Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N
    Yang Y; Yan Y; Yin J; Tang N; Wang K; Huang L; Hu J; Feng Z; Gao Q; Huang A
    Signal Transduct Target Ther; 2023 Feb; 8(1):63. PubMed ID: 36765030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N
    Li J; Zhang H; Wang H
    Comput Struct Biotechnol J; 2022; 20():6578-6585. PubMed ID: 36467585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and Validation of circRNA-miRNA Network in Regulating m
    Chi F; Cao Y; Chen Y
    Front Oncol; 2021; 11():560506. PubMed ID: 33708621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.
    Wu Q; Xie X; Huang Y; Meng S; Li Y; Wang H; Hu Y
    J Cancer; 2021; 12(3):682-692. PubMed ID: 33403026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
    Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
    Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m
    Yu J; She Y; Yang L; Zhuang M; Han P; Liu J; Lin X; Wang N; Chen M; Jiang C; Zhang Y; Yuan Y; Ji SJ
    Adv Sci (Weinh); 2021 Nov; 8(22):e2101329. PubMed ID: 34643063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
    Luo X; Cao M; Gao F; He X
    Exp Hematol Oncol; 2021 Jun; 10(1):35. PubMed ID: 34088349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Liao Y; Liu Y; Yu C; Lei Q; Cheng J; Kong W; Yu Y; Zhuang X; Sun W; Yin S; Cai G; Huang H
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302025. PubMed ID: 37515378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological function of m6A reader YTHDF2 and its role in human disease.
    Wang JY; Lu AQ
    Cancer Cell Int; 2021 Feb; 21(1):109. PubMed ID: 33593354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Li G; Zhang Y; Du X; Li W; Zhang Y; Han T; Zheng Z
    Transl Cancer Res; 2020 Jan; 9(1):323-334. PubMed ID: 35117186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.